HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertise
  • Subscribe

Decubitus Ulcer Treatment Products Market to Reach $3.6 billion by 2010

April 25, 2008 by HME Business

As the population ages and requires more long-term care, so to will the demand for treating decubitus ulcers, which will push the market for ulcer treatment products to $3.6 billion by 2010, according to The Decubitus Ulcer Treatment Products Market Report from market watchers at Global Industry Analysts Inc.

Decubitus ulcers result from tissue damage caused by patient bodyweight. Because of the incrase in homecare services targeted toward older patients, the market is continually trying to drive new innovations specifically for the homecare environment, according to the report.

Some other findings from the report:

  • The United States has largest incidence of decubitus ulcers, making it the largest market for decubitus ulcer treatment products. U.S. sales of low air loss beds are projected to reach $309 million by 2009.
     
  • Europe follows closely behind the United Sates as the second largest market for decubitus ulcer treatment products.
  • Alternating air pressure mattresses market in Europe represents the largest segment, estimated at $248 million for 2008.  France, Germany, Italy, United Kingdom collectively account for more than 70 percent share of the European market.
  • Asia-Pacific represents one of the fastest growing markets for decubitus ulcer treatment products. The market is projected to grow at a compounded annual rate of 6 percent over the period 2000-2010.
  • The foam mattress market in Japan is estimated at $31 million for 2008. Growth in the segment is likely to be driven by increased usage of foam mattresses as an inexpensive treatment product.

Related Articles Read More >

NCPA Announces New Senior Vice President of the Office of CEO
Sara Roszak is an industry veteran who most recently served at the National Association of Chain Drug Stores.
More HCPCS Codes to Be Added to Medicare Prior Authorization Process in October
Prior authorization will be required for eight additional codes for dates of service of Oct. 28 and later.
M&A Update, Part 2: What Makes a Good Investment or Acquisition?
At the HME Business FUTURE conference, experts on mergers and acquisitions took the stage.
Frazier Healthcare Acquires MatrixCare, Appoints CEO
MatrixCare was owned by Resmed.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertise
  • Subscribe